Cerba Research Usa, Inc.

Cerba Research USA Inc. is a for-profit corporate entity that provides clinical trial and laboratory services to support biomedical research. The company maintains CLIA certification and qualifications to conduct clinical laboratory testing and provide associated data management for multi-center clinical trials.

Cerba Research has been awarded several federal contracts and purchase orders from HHS agencies including the National Institutes of Health's National Institute of Allergy and Infectious Diseases, National Human Genome Research Institute, and National Cancer Institute. These have included firm fixed price awards to provide COVID-19 testing support, clinical chemistry panels for genomic research in West African populations, and serum biomarker assays. The awards have funded work to be performed at the company's New York laboratory, with no subcontractors indicated.

Additionally, Cerba Research holds a $5 million single-award indefinite delivery contract from the National Institute of Allergy and Infectious Diseases to supply clinical central laboratory services over a 5-year period in support of the Institute's vaccine and therapeutic clinical trials program. Two delivery orders totaling over $2 million have been issued to date under this vehicle for SARS-CoV-2 testing and general clinical trial support services.

We streamline study setup,site preparation, sample collection, and results reporting. Our comprehensive service portfolio covers all aspects of the clinical trial process, including sampling kit preparation, onsite handling instructions, courier transport, sample tracking, contingency planning, lab management, post-study storage, and sample retrieval and distribution to referral labs.